These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19404394)

  • 21. CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres.
    Walter D; Satheesha S; Albrecht P; Bornhauser BC; D'Alessandro V; Oesch SM; Rehrauer H; Leuschner I; Koscielniak E; Gengler C; Moch H; Bernasconi M; Niggli FK; Schäfer BW;
    PLoS One; 2011; 6(5):e19506. PubMed ID: 21602936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma.
    Patel GK; Yee CL; Terunuma A; Telford WG; Voong N; Yuspa SH; Vogel JC
    J Invest Dermatol; 2012 Feb; 132(2):401-9. PubMed ID: 22011906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD133 induces tumour-initiating properties in HEK293 cells.
    Canis M; Lechner A; Mack B; Zengel P; Laubender RP; Koehler U; Heissmeyer V; Gires O
    Tumour Biol; 2013 Feb; 34(1):437-43. PubMed ID: 23150174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
    Yu D; Jin CS; Chen O; Wen LJ; Gao LF
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
    Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and expansion of human colon-cancer-initiating cells.
    Ricci-Vitiani L; Lombardi DG; Pilozzi E; Biffoni M; Todaro M; Peschle C; De Maria R
    Nature; 2007 Jan; 445(7123):111-5. PubMed ID: 17122771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133 expression in chemo-resistant Ewing sarcoma cells.
    Jiang X; Gwye Y; Russell D; Cao C; Douglas D; Hung L; Kovar H; Triche TJ; Lawlor ER
    BMC Cancer; 2010 Mar; 10():116. PubMed ID: 20346143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.
    Ding W; Mouzaki M; You H; Laird JC; Mato J; Lu SC; Rountree CB
    Hepatology; 2009 Apr; 49(4):1277-86. PubMed ID: 19115422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
    Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
    Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.
    Donnenberg VS; Donnenberg AD; Zimmerlin L; Landreneau RJ; Bhargava R; Wetzel RA; Basse P; Brufsky AM
    Cytometry B Clin Cytom; 2010 Sep; 78(5):287-301. PubMed ID: 20533389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.